The preclinical journey: transitioning a novel cell therapy into early phase clinical trials

Cell & Gene Therapy Insights 2024; 10(2), 171–177

DOI: 10.18609/cgti.2024.024

Published: 6 March
Interview
Silvio Manfredo-Vieira


Abi Pinchbeck, Commissioning Editor, Cell & Gene Therapy Insights, speaks to Silvio Manfredo-Vieira, Associate Director for Correlative and Translational Studies at the Department of Dermatology, University of Pennsylvania, about his role directing the translational research to move novel cell therapies from the lab into early phase clinical trials and pioneering a chimeric auto-antibody receptor to target B-cell-mediated diseases.